The stock of UnitedHealth Group Incorporated (NYSE:UNH) increased by $5.48 on Tuesday to finish at $497.56, up 1.11 percent. The last five days have seen an average of 3,012,000 shares of common stock traded. 17 times new highs were reached in the current year, with a fall of -$4.58. The average number of shares traded over the last 20 days was 3,179,710, while the average volume over the last 50 days totaled 3,136,306.
UNH stock dropped -5.09% since last month. On 05/19/22, the company’s shares reached a one-month low of $463.33. The stock touched a high of $553.29 on 04/14/22, after rallying from a low of $383.12 in 52 weeks. The price of UNH stock has declined by -0.91% or -$4.58 this year, reaching a new high 17 times. Still, the stock price is down -10.07% from the 52-week high.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
There have been 6 days since UnitedHealth Group Incorporated (UNH) last reported insider trading activity on May 19. On May 19, Director BURKE RICHARD T sold 2,500 shares at $478.96 each. This transaction resulted in the insider making $1,197,410. On May 17, BURKE RICHARD T sold 2,500 shares at a price of US$493.50. After the transaction, the insider now owns 1,217,500 shares. Director BURKE RICHARD T had earlier sold 2,500 shares on May 16 for $493.25 a share. The transaction was completed for $1,233,125.
UnitedHealth Group Incorporated (UNH) has a trailing price-to-earnings (P/E) ratio of 27.24. Beta for the stock is 0.84. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.55, the price-to-book (PB) ratio of 6.43, and the price-to-cash flow ratio of 33.44.
Company paid $1.45 per share in dividends, remained unchanged from $1.45 last year. A $0.20 dividend increase was reported on Wednesday June 9 2021.
The company’s long-term debt to equity ratio for the quarter ending March 30 is 0.56, and the total debt to equity ratio is 0.65. UnitedHealth Group Incorporated’s operating margin stood at 8.10% for the same period. Based on annual data, it had gross profit of $69.65 billion and revenue of $287.6 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. UNH’s return on assets (ROA) during the last 12 months has been 8.10%. There was a 16.50% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 24.60%.
According to UnitedHealth Group Incorporated’s quarterly financial report for the quarter that ended March 30. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $80.15 billion, while revenues rose by 12.42% to $73.74 billion. It was predicted that UnitedHealth Group Incorporated’s quarterly earnings would be $5.49, but it ended up being $5.38, beating the consensus by 2.00%. EBITDA was $7.74 billion for the quarter. At the end of UnitedHealth Group Incorporated’s most recent quarter ended March 30, its liabilities totaled 145.11 billion, while its total debt was $47.49 billion. Equity owned by shareholders amounts to $938.17 million.
Here’s a quick look at UnitedHealth Group Incorporated’s (UNH) price momentum from a technical perspective. As of 24 May, the RSI 9-day stood at 53.78%, suggesting the stock is Neutral, with a 29.55% historical volatility rate.
The stochastic %K and %D were 60.12% and 44.69% respectively, while the average true range (ATR) was 13.85. Based on the 14-day stochastic reading of 72.31%, the RSI (14) reading is 49.90%. On the 9-day MACD Oscillator, the stock is at 6.10, and the 14-day reading is at 4.21.
In its analyst report released on December 14, 2021, Goldman began covering UnitedHealth Group Incorporated (NYSE: UNH). The stock was rated as a Buy by the brokerage firm.
What is UNH’s price target for the next 12 months?
The current consensus forecast for the stock is between $480.00 and $632.00, with a median target price of $595.00. In analyzing these forecasts, the average price target given by analysts for UnitedHealth Group Incorporated (UNH) is $580.95.